EXEGENESIS BIO
Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development.
EXEGENESIS BIO
Industry:
Biotechnology Health Care Therapeutics
Founded:
2019-01-01
Address:
Lansdale, Pennsylvania, United States
Country:
United States
Website Url:
http://www.exegenesisbio.com
Total Employee:
1+
Status:
Active
Total Funding:
10 M USD
Technology used in webpage:
SPF Amazon Microsoft Azure DNS Amazon Oregon Region HiChina DNS
Current Employees Featured
Founder
Investors List
LYFE Capital
LYFE Capital investment in Series B - Exegenesis Bio
Kaitai Capital
Kaitai Capital investment in Series B - Exegenesis Bio
Legend Capital
Legend Capital investment in Series B - Exegenesis Bio
BioTrack Capital
BioTrack Capital investment in Series B - Exegenesis Bio
Xianfeng Qiyun
Xianfeng Qiyun investment in Series B - Exegenesis Bio
Hillhouse Capital Group
Hillhouse Capital Group investment in Series B - Exegenesis Bio
Kaitai Capital
Kaitai Capital investment in Seed Round - Exegenesis Bio
K2VC
K2VC investment in Seed Round - Exegenesis Bio
Lenovo Star
Lenovo Star investment in Seed Round - Exegenesis Bio
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-16 | Exegenesis Bio Appoints Mahen Gundecha Chief Business Officer |
Official Site Inspections
http://www.exegenesisbio.com Semrush global rank: 5.72 M Semrush visits lastest month: 1.46 K
- Host name: 236.122.206.35.bc.googleusercontent.com
- IP address: 35.206.122.236
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Exegenesis Bio"
About Us - Exegenesis Bio
PA Office: Springhouse Innovation Park Building# 3 727 Norristown Rd. Suite# 160 Lower Gwynedd, PA 19002, USASee details»
Exegenesis Bio - Crunchbase Company Profile & Funding
Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and โฆSee details»
Exegenesis Bio, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Www.exegenesisbio.com. Startups | Private Company | Subsidiary Company | 2019 | Pennsylvania, United States | 50-100 | www.exegenesisbio.com. Last update 29 Sep 2024. โฆSee details»
Exegenesis Bio Overview | SignalHire Company Profile
Exegenesis Bio Employees Size. 100-200 employees. Specialties. Gene Therapy, Biotechnology, Cell Therapy, AAV, Spinal Muscular Atrophy, Eye Diseases, Hemophilia, CNS ...See details»
Exegenesis Bio - LinkedIn
Exegenesis Bio is a clinical stage global gene therapy company with operations in Philadelphia, Boston and China. The companyโs innovative gene therapy pipeline is based on proprietary โฆSee details»
Exegenesis Bio - Org Chart, Teams, Culture & Jobs
View Exegenesis Bio's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Exegenesis Bio - workinbiotech.com
Exegenesis Bio is a multinational company advancing innovative gene and cell therapies focused on three initial areas: central nervous system (CNS), ophthalmology and liver. To advance โฆSee details»
Exegenesis Bio - VentureRadar
Advances an early to clinical-stage gene therapy pipeline focused on CNS, ophthalmology, and liver areas, utilizing proprietary discovery and manufacturing platforms for research and โฆSee details»
Exegenesis Bio | Biotech Careers
Exegenesis Bio is a clinical-stage global cell and gene therapy company that operates in Philadelphia, Boston, China, and Singapore. The company is working on a pipeline of gene โฆSee details»
Exegenesis Bio - Overview, News & Similar companies - ZoomInfo
Who is Exegenesis Bio. Exegenesis Bio is a clinical stage global gene therapy company with operations in Philadelphia, Boston and China. The company's innovative gene the rapy โฆSee details»
Exegenesis Company Profile 2024: Valuation, Funding & Investors
Exegenesis General Information Description. Developer of a gene therapy treatments. The company mainly focuses on the research and development of gene therapy drugs and โฆSee details»
Exegenesis Bio Opens Philadelphia and Boston Offices and โฆ
Sep 8, 2021 This is the right time for us to establish our US organization as we prepare to double in size during the next year. Many of our new roles will be based in Philadelphia and โฆSee details»
Exegenesis Bio - Products, Competitors, Financials, Employees ...
Exegenesisbio.com. Overview & Products; Financials; Founded Year 2019. Stage Other Investors | Alive. Mosaic Score. The Mosaic Score is an algorithm that measures the overall financial โฆSee details»
Exegenesis Bio: Revenue, Competitors, Alternatives
Exegenesis Bio top competitors are Western Oncolytics Ltd., Holganix and Montrose Broadcasting Corp and they have annual revenue of $3.3M and 21 employees.See details»
Exegenesis Bio | ้ข่ฑ - ้ข่ฑ (ไธญๅฝ)
Exegenesis Bio | ๅจ้ข่ฑไธๆ 1,267 ไฝๅ ณๆณจ่ ใWe are reimagining ways to develop & manufacture gene therapies. Our mission is to improve efficacy, safety & access. | Exegenesis โฆSee details»
Exegenesis Bio Opens Philadelphia and Boston Offices and โฆ
Sep 8, 2021 This is the right time for us to establish our US organization as we prepare to double in size during the next year. Many of our new roles will be based in Philadelphia and โฆSee details»
Careers - Exegenesis Bio
Ownership. We are equally accountable for the business's success; we do the right thing even when nobody is watching. We take pride in what we are doing and demonstrate initiative in โฆSee details»
Exegenesis Bio - VentureRadar
Exegenesis Bio is advancing an early to clinical-stage gene therapy pipeline with three initial focused therapeutic areas: CNS, ophthalmology, and... ... Find out ...See details»
Exegenesis Bio Completes Series B++ Financing; Raises $120 M to โฆ
PHILADELPHIA, PA, June 23, 2021 (BUSINESS WIRE) โ Exegenesis Bio, a rapidly growing global gene therapy company, developing innovative genetic medicines for eye, CNS and liver โฆSee details»